A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
for Invasive Mold Infections
Sites in Houston, San Antonio +17 more locations
Sponsor: Basilea Pharmaceutica
Sex: All·Age: 18+
Code: NCT06925321·Phase 3·Recruiting·Listed Apr 2025